Indonesia COVID-19 vaccine

Propelled by the Omicron variant, the country's daily caseload has increased more than 30-fold in just under a month.

But Southeast Asia's largest country is not quite out of the woods yet.

President Joko Widodo said that the development of infrastructure and "quality human capital" will remain priorities for the remainder of his second term.

Just as cases are beginning to ease in densely populated Java and Bali, they are rising elsewhere.

Will mounting evidence about the limited efficacy of Chinese-made vaccines spell the end for Beijing's vaccine diplomacy?

Beijing's comments on “vaccine nationalism” hints at its desire to position itself as the vaccine supplier of first resort to the developing world.

The Gotong Royong plan for corporate employees will likely give rise to vivid perceptions among the public that the rich enjoy preferential access to coveted vaccines.